CoChat

Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016

Open access
Tanaka, Atsushi, Ma, Xiong, Yokosuka, Osamu, Weltman, Martin, You, Hong, Amarapurkar, Deepak N., Kim, Yoon Jun, Abbas, Zaigham, Payawal, Diana A., Chang, Ming-Ling, Efe, Cumali, Ozaslan, Ersan, Abe, Masanori, Mitchell-Thain, Robert, Zeniya, Mikio, Han, Kwang Hyub, Vierling, John M., Takikawa, Hajime · 2016 · Hepatology International
Cited by 55

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

During the 25th annual meeting of the Asia–Pacific Association for the Study of the Liver (APASL 2016) in Tokyo, we organized and moderated an inaugural satellite symposium on the autoimmune liver diseases, autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC). Following the keynote lecture by John M. Vierling (USA), speakers from the Asia–Pacific region provided an up-to-date perspective on the epidemiology, clinical practice and research in AIH and PBC in the Asia–Pacific region. Although epidemiology and clinical features of AIH seem to be similar in East Asia compared to those in western countries, the majority of patients with AIH are detected at an advanced stage and have higher mortality rates in South Asia, indicating an unmet need for earlier diagnosis and the initiation of appropriate immunosuppressive treatment. PBC is more commonly seen in Australia and East Asia. As of 2016, clinical practice guidelines (CPG) for PBC have been published in Japan and China. Ursodeoxycholic acid (UDCA) is recommended as a first-line therapy by both CPG. Nevertheless, one of the unmet therapeutic needs in PBC is the treatment of patients refractory to or intolerant of UDCA. It is of interest that the prevalence of chronic hepatitis B (CHB) in PBC patients was low in Taiwan and mainland China where the prevalence of CHB is very high. In this review, we overview this exciting and epoch-making symposium.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12072-016-9767-9

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 55

Metadata

Authors
Tanaka, A., Ma, X., Yokosuka, O., Weltman, M., You, H., Amarapurkar, D. N., Kim, Y. J., Abbas, Z., Payawal, D. A., Chang, M.-L., Efe, C., Ozaslan, E., Abe, M., Mitchell-Thain, R., Zeniya, M., Han, K. H., Vierling, J. M., & Takikawa, H.
Venue
Hepatology International
Published
2016-09-20
Volume
10
Issue
6
Pages
909-915
ISSN
  • 1936-0533 (ISSN-L)
  • 1936-0541
OpenAlex
W2521052824
Cited by
55
References
15
FWCI
3.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. https://app.cochat.ai/papers/10.1007/s12072-016-9767-9
The paper
Tanaka, A., Ma, X., Yokosuka, O., Weltman, M., You, H., Amarapurkar, D. N., Kim, Y. J., Abbas, Z., Payawal, D. A., Chang, M.-L., Efe, C., Ozaslan, E., Abe, M., Mitchell-Thain, R., Zeniya, M., Han, K. H., Vierling, J. M., & Takikawa, H. (2016). Autoimmune liver diseases in the Asia–Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. Hepatology International. https://doi.org/10.1007/s12072-016-9767-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.